Updated on February 10, 2023

This data is meant to be used for educational purposes to inform providers, patients, insurers, and state Medicaid agencies what genetic services may or may not be written into each state’s Medicaid policy. The database is not meant to indicate or imply whether a certain program will cover a specific service, since many decisions are made on a case by case basis. If you have specific questions about whether a service is covered, you should reach out to your plan administrator. Please see this disclaimer below for more information.

Medicaid Coverage Information Published


State Contact Information

Kelly Cunningham, Medicaid Administrator

General Genetic Testing Criteria

Genetic Testing Not Covered

State Specific Definition

Genetic Services for Children

Every infant with confirmed hearing loss should be evaluated by an otolaryngologist with knowledge of pediatric hearing loss and have at least one examination to assess visual acuity by an ophthalmologist experienced in evaluating infants. A genetics consultation should be offered to families of children with congenital hearing or vision deficits.

Genetic Counseling Requirement

A physician may submit a bill for services rendered by an Advanced Practice Nurse (APN), a Physician Assistant (PA) or a Genetic Counselor, as long as such practice is in accordance with the policy outlined in this handbook or not in conflict with the following rules and regulations:

  1. Physician Assistant Practice Act (225 ILCS 95)
  2. Genetic Counselor Licensing Act (225 ILCS 135)
  3. Department of Professional Regulations rules for administration of Physician Assistant Practice Act (68 Ill. Adm. Code 1350)

Metabolic Formula Coverage Legislation

Metabolic Formula Coverage & Criteria

Prior Authorization Requirements

Prior Authorization Forms

Fee Schedule

BRCA Testing Coverage

Coverage is available.

Requirements for BRCA

Under the Meridian care plan, which applies to Illinois Medicaid:

Criteria for Coverage (To be used for requests not listed under specific diagnoses):

  • There must be evidence that the requested test is clinically appropriate. Detailed documentation is provided that
    supports test results will be used to significantly alter the management or treatment of the member (e.g. surgery,
    the extent of surgery, a change in surveillance, hormonal manipulation, choice of medication, or a change from
    standard therapeutic or adjuvant chemotherapy.
  • Clinical documentation should be submitted that suggests a key genetic disorder is present, which can be
    indicated by the following:

    • Clinical features indicative of a condition or disease with suspected genetic etiology; OR
    • High risk of inheriting the disease based upon personal history, family history, documentation of a
      genetic mutation and/or ethnic background; OR
    • Following history, physical examination, pedigree analysis and completion of conventional
      diagnostic testing, a definitive diagnosis remains uncertain and a hereditary diagnosis is suspected,

Cystic Fibrosis Screening

Hereditary Cancer Testing Coverage

Under Meridian Medicaid, certain cancers are covered.

Lynch Syndrome Testing Coverage

hMLH1, hMSH2, hMSH6 and PMS2 gene tests are covered to diagnose Lynch syndrome.
Criteria for Lynch syndrome genetic testing includes:

  1. At least two close relatives of the affected beneficiary must have or have had a cancer associated with Lynch syndrome; and all of the following criteria must be present:
    1. One must be a first-degree relative of the other two;
    2. At least two successive generations must be affected;
    3. At least one of the relatives or the beneficiary with cancer associated with hereditary nonpolyposis colorectal cancer should be diagnosed before the age 50 years;
    4. Familial adenomatous polyposis (FAP) should be excluded in the colorectal cancer case(s) (if any);
    5. Histologic diagnosis of tumors should be verified whenever possible.

Microarray Testing

Newborn Screening

<p>Newborn metabolic screening is required by state mandate to screen all Illinois newborns for over 40 life threatening metabolic, endocrine and hemoglobin disorders soon after birth to prevent death and/or developmental disabilities. All newborn screening blood specimens are collected 24 hours after birth and submitted to the Illinois Department of Public Health (IDPH) centralized laboratory.</p>

Panel Testing

Pharmacogenetic Testing

Prenatal Testing Offered

Whole Exome Sequencing

Other Tests Covered

Other Information

The llinois Department of Public Health (IDPH) offers a Genetics Program “to provide access to appropriate genetic services for any family with concerns about an inherited condition, and to increase awareness of services provided by the program among health care providers and consumers. Genetic services are available to families or persons of any age residing in Illinois, who may have a family history of, or concern about a medical condition with a genetic basis.



  • Medical Provider Handbook: Chapter 200 , Durable Medical Equipment
  • Medical Provider Handbook: Chapter 200, Healthy Kids manual
    Medical Provider Handbook: Chapter 200, Practitioners Handbook
  • Family Planning and Reproductive Health Services Provider Notice (6/26/14) Meridian Health Plan BRCA/Lynch/Hereditary Cancer:
  • Newborn Screening:
Newborn Screening Reimbursement


Disclaimer: The information contained in the database has been obtained from sources believed to be reliable but NCC has not attempted to validate or confirm the information. The database may be updated periodically. However, the accuracy and completeness of the information contained in the database cannot be, and is not, guaranteed. NCC makes no warranty of the accuracy, completeness or timeliness of this information, and shall not be liable for any decision made in reliance on this information. It is the user’s responsibility to verify this information by contacting the state Medicaid agency directly.

The database contains links to third-party websites. These links are provided solely as a convenience to users and not as a guarantee, warrantee, or recommendation by NCC of the content on such third-party websites or as an indication of any affiliation, sponsorship or endorsement of such third party websites. NCC is not responsible for the content of linked third-party sites and does not make any representations regarding the privacy practices of, or the content or accuracy of materials on, such third-party websites. If you decide to access linked third-party websites, you do so at your own risk. Your use of third-party websites is subject to the terms of use for such sites.